[Modern trends in the development of radioprotective formulations (a review of the literature)].
D008735:5-Methoxytryptamine / Q000494:pharmacology; D000818:Animals; D002626:Chemistry, Pharmaceutical; D003538:Cystamine / Q000494:pharmacology; D003539:Cystaphos / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004357:Drug Synergism; D006632:Histamine / Q000494:pharmacology; D051379:Mice; D011837:Radiation-Protective Agents / Q000494:pharmacology* / Q000633:toxicity; D012106:Research; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D000338:beta-Aminoethyl Isothiourea / Q000494:pharmacology
D004338:Drug Combinations; D011837:Radiation-Protective Agents; D013438:Sulfhydryl Compounds; D000338:beta-Aminoethyl Isothiourea; D008735:5-Methoxytryptamine; D006632:Histamine; D003538:Cystamine; D003539:Cystaphos
Sovremennye tendentsii v razrabotke radiozashchitnykh retseptur (obzor literatury).